Phil Rosen of Opening Bell Daily returns to Inside the ICE House to break down the Fed’s expected rate cut and its broader economic impact. He highlights a 911,000-job downward revision as a warning sign for the labor market and explains why Powell’s messaging will be closely watched. Despite soft jobs data, Phil points to strong earnings and AI momentum as key supports for markets. Looking ahead, he cautions that while rate cuts may offer short-term relief, stabilizing the labor market remains the bigger challenge.

The sports media industry is transforming as fans shift to streaming, personalization, and on-demand access. With a vast portfolio of rights, technology, and storytelling, ESPN is redefining how audiences experience live sports and highlights across every screen. Jimmy Pitaro, ESPN's Chairman, goes Inside the ICE House to discuss its direct-to-consumer future, expanded partnerships with the NFL and WWE, and how the network is positioning itself to remain the front door for sports fans in a rapidly changing media landscape.

Eric Criscuolo, Market Strategist at the NYSE, recaps a week of mixed equity performance, with AI and semiconductor stocks leading while Apple lagged. Labor data revisions and rising jobless claims signaled a softer job market, raising Fed policy questions. Inflation data was mixed, with PPI cooling but CPI still elevated. Commodities saw a major copper merger and modest oil gains. Criscuolo flags next week’s Fed decision and Powell’s press conference as key market drivers.

Enveda Biosciences is using AI to decode nature’s vast chemical library and transform it into breakthrough medicines. Founded in 2019 by Viswa Colluru, the company is advancing first-in-class therapies like ENV-294 while cutting the time and cost of drug discovery. Colluru joins Inside the ICE House to share how Enveda is reimagining the playbook for modern medicine and building a healthier future for patients worldwide.

Nimbus Therapeutics is transforming drug discovery with computational chemistry and AI to design small molecules that precisely target disease. CEO Abbas Kazimi, who took the helm in March, is driving a “fail fast” approach that balances discipline with innovation. He joins Inside the ICE House to share how Nimbus is scaling its pipeline and shaping the future of precision medicine.

Michael Reinking, Senior Market Strategist for the NYSE, recaps a choppy week driven by tariff uncertainty, tech earnings misses, and focus on the upcoming jobs report. He notes August ended strong for small and mid-caps, but September’s seasonal weakness and rising global yields remain risks. Labor data showed slower hiring and AI-linked layoffs, though productivity gains offered a bright spot. Reinking flags the jobs report, expected Fed rate cuts, and inflation data as key drivers ahead.

AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. Eli Lilly is leading the way, appointing Thomas Fuchs as its first Chief AI Officer to integrate AI across its pipeline. A NASA and Mount Sinai veteran, Fuchs is turning Lilly’s data into a competitive edge. He joins Inside the ICE House to share how Lilly is building the AI-powered medicine company of the future.

Alex Zweber, Portfolio Manager and Strategist at Parametric under Morgan Stanley Investment Management, joins Bilal Little, Director of Exchange Traded Products at the NYSE, to share his journey from derivatives trading to leading Parametrics' liquid alternatives team. He discusses the explosive growth of ETFs for income, protection, and growth, and how Parametric is bringing decades of institutional expertise into the ETF wrapper. 

The future of mental health is being transformed, moving beyond trial-and-error treatments to science-driven precision. Breakthroughs in neuroscience, AI, and precision medicine are mapping the brain’s unique biological signatures, creating pathways for personalized care. Alto Neuroscience is at the forefront, using brain biomarkers and AI to match patients with the right therapies—fast. Founded in 2019 by Dr. Amit Etkin, the company is rewriting the rules of mental health treatment. He goes Inside the ICE house to explain how Alto is turning guesswork into guided science and offering hope where it once felt out of reach.

In August, Inside the ICE House aired five new episodes, four traditional Inside the ICE House episodes, and one episode that kicked off a new, monthly series.

Episode 480: Elanco CEO Jeff Simmons on Protecting Our Pets & Advancing Animal Health

Episode 481: Edwards Lifesciences CEO Bernard Zovighian on Engineering Hope & Pioneering Purpose

August Markets in Focus: Inside the ICE House x Opening Bell Daily

Episode 482: Houlihan Lokey CEO Scott Adelson on Markets, M&A, and Building a Global Powerhouse

Episode 483: W&T Offshore CEO Tracy Krohn on Steering Oil and Gas Exploration Through Industry Transformation